『无忧PPT』PPT免费下载,PPT素材,PPT背景PPT图片PPT模板PPT制作免费下载的门户网站Rss 2.0无忧PPT-PPT门户网站

PPT模板下载排行榜(New) 无忧PPT原创PPT模板 无忧PPT官方微博 精品PPT模板

麦肯锡给医药行业的报告PPT资源下载

::推荐PPT模板::
  • ::麦肯锡给医药行业的报告下载地址::
  • 下载地址1  
  • 上传作者:chinappt
  • 来源:麦肯锡给医药行业的报告|PowerPoint资源|免费下载|PPT模板|PPT金融资源|PowerPoint工具|医院医疗|PPTresources|PPT资源|医疗卫生PPT
  • 麦肯锡给医药行业的报告简介
  • 麦肯锡给医药行业的报告


    McKinsey was commissioned in Q1, 2003 to:
    provide dedicated effort in conducting in-depth market survey and collect detailed information from 4 cities within 2 provinces to identify the key growth drivers in China’s broad market;
    4 product categories were included: G.I. (Motilium), OBGY (Gyno.), Nail Infection (Sporanox) & Vertigo (Sibelium)
    provide objective assessment about the broad market opportunity (not including any urban centres);
    provide business model / proposal for XJP to capture the broad market
    McKinsey Broad Market Study Process
    Project design (Q1, 2003)
    Project review with local and regional J-C team (Apr. 03)
    Survey market selection (Apr. 03)
    Field work in 2 cities in Shandong (May 03)
    1st interim report (mid-June 03)
    Field work in 2 cities in Sichuan (mid-June – mid-July 03)
    2nd interim report and Killer Idea workshop (end July 03)
    Final report (Aug. 03)
    Presentation to corporate management (Sept. 03)

    BROAD MARKET CAN BE DEFINED AS CLASS 2 HOSPITALS AND BELOW AT REGIONAL CITY LEVEL AND ALL HEALTH CARE INSITITUTIONS AT COUNTY LEVEL AND BELOW
    BROAD MARKET DRUGS INCLUDE OTC AND “OUT PATIENT” Rx DRUGS
    McKinsey Key Findings Overall Market Situation
    BROAD MARKET REPRESENTS 94% OF OVERALL DEMAND FOR BROAD MARKET DRUGS
    Class 3 hospital
    DUE TO LOW INSURANCE COVERAGE AND RECENT REIMBURSEMENT POLICIY CHANGES, MOST PATIENTS PAY BROAD MARKET DRUGS BY THEMSELVES
    Insurance coverage in Yantai & Jining
    PATIENTS GO TO PHARMACY/CLINICS FOR MINOR SYMPTOMS
    A LARGE PROPORTION OF DRUG SALES COMES FROM RETAIL PHARMACIES; PHARMACY CLERKS BECOME INFLUENTIAL
    CLINICS ARE PLAYING IMPORTANT ROLE ESPECIALLY AT COUNTY AND TOWN AND BELOW
    G.I. Category Review
    FOR GI DISFUNCTION DRUGS AS A WHOLE THERE IS SIGNIFICANT LATENT DEMAND; PEOPLE GENERALLY SEEK TREATMENT IN CLINICS AND PHARMACIES
    FOR GI DRUGS, POLARIZATION IS BECOMING MORE OBVIOUS
    SALES OF GI DRUGS ARE MORE CONCENTRATED TOWARDS VILLAGE AND COUNTY, WHILE THE MARKET IS FRAGMENTED WITH MANY DIFFERENT DRUGS
    IN BROAD MARKET, MOTILIUM IS LOSING OUT BIG TIME IN RETAIL PHARMACY CHANNEL …
    … AND IN COUNTY GEOGRAPHY
    Vaginal Infection Category Review
    FOR VAGINAL INFECTIONS, PATIENTS ARE MORE AWARE OF THE DISEASE AND GO TO HOSPITAL FOR TREATMENT
    FOR GYNO DAKTARIN, HOSPITAL IS CRITICAL FOR PRESCRIPTION BUT PURCHASING HAS BEEN GRADUALLY SHIFTING TO RETAIL PHARMACY
    IN ADDITION, GYNO DAKTARIN NEEDS TO GROW THE MARKET SHARE ESPECIALLY THOSE OF COUNTY AND TOWN
    Nail Fungal Infection Category Review
    FOR TINEA UNQUIUM DRUGS, DEMAND LATENCY IS EVEN HIGHER
    HOSPITAL CHANNEL IS STILL DOMINATING TINEA UNQUIUM DRUG MARKET WHILE PHARMACY CHANNEL IS PICKING UP
    THERE  ARE ONLY A FEW COMPETITORS AT CITY AND COUNTY LEVEL FOR SPORANOX; LIANGJIA IS DOING BETTER THAN SPORANOX AT RETAIL PHARMACIES DUE TO HEAVY ADVERTISING
    THERE  ARE ONLY A FEW COMPETITORS AT CITY AND COUNTY LEVEL FOR SPORANOX; LIANGJIA IS DOING BETTER THAN SPORANOX AT RETAIL PHARMACIES DUE TO HEAVY ADVERTISING
    PRICE IS A HUGE ISSUE FOR SPORANOX
    FOR SPORANOX, XJP SHOULD CONTINUE TO FOCUS ON HOSPITALS …
    … AND AT CITY AND RICH COUNTIES
    Vertigo Drug Category Review
    THERE IS UNTAPPED DEMAND IN TWO OF THE THREE PRODUCT-RELATED TAs
    BY GEOGRAPHY, COUNTY LEVEL AND ABOVE CONSUME A DOMINANT SHARE OF SIBELIUM
    McKinsey Broad Market Proposal
    WE NEED TO SOLVE THREE CRITICAL ISSUES TO ACHIEVE OUR ASPIRATION FOR BROAD MARKET
    XJP NEEDS TO INVEST TO CAPTURE THE GREAT POTENTIAL IN BROAD MARKET
    DURING OUR KILLER IDEA WORKSHOP, WE DEVELOPED FOUR SETS OF HYPOTHESIS TO BE TESTED IN PILOT
    Comments on the McKinsey Proposed Initiatives
    Hospital Seeding
    Besides testing the idea to conduct professional detailing to the county hospitals, we also want to provide coverage among the smaller hospitals (Tier I & II ) in the urban cities to compare the R.O.I.s

    Pharmacy Plus
    We have seen competitors (like SiDaShu) sales growth via aggressive coverage and promotion among the drugstores in the richer countis.  So, this is definitely worth testing.

    Comments on the McKinsey Proposed Initiatives
    Distributor Drive
    We have expanded our distribution network to include almost 1,000 sub-distributors in the last 3 years.  We will try to test the sales impact if we invest more program and resources among them.

    Turbo CME
    We have started CME program among county hospital doctors.  It would be interested to find out the sales contribution if we conduct the program among the barefoot doctors.

    XJP COULD ADOPT A THREE-PHASED ACTION PLAN TO ESTABLISH AND MAINTAIN DOMINANT POSITION IN BROAD MARKET
    REVENUE FORECAST OF  NATIONAL ROLL-OUT
    Eye Opening Key Learnings
    Development of G.P. clinics
    Lack of sensitivity of reimbursement in the broad market due to new M.I. System
    Speed of retail drugstore development and influence in patient product choice
    Prescription spill over to the retail outlets
    Our Conclusions
    The potential of the broad market is once again confirmed by the McKinsey study
    The fast development of drugstores and the polarization of hospitals sales are aligned with our understanding
    Agree with McKinsey’s finding regarding our share loss in the broad market (especially among county level drugstores) to local competitors and generic products
    Testing the different proposal initiatives with dedicated resources and monitoring effort will enable us to focus on the key business drivers for future broad market expansion

    Our Proposed Action Steps
    Seek management approval for the broad market pilot test in 2004
    Assume approval is obtained before Nov. 1,
    Select internal candidate to be project leader
    Form the project task force with marketing, sales and market research members
    Recruit and train the broad market team
    Kick off the plan by Feb. 1 after CNY
    Our Proposed Pilot Test
    Our Proposed Pilot Test Schedule
    Management Approval  Nov. 1, 03
    Recruitment     Nov. – Dec., 03
    Training     Jan., 04
    Pre-test survey    Jan., 04
    Pilot Test begins    Feb., 04
    1st Assessment (with 3 months data) June, 04
    2nd Assessment (with 6 months data) Sept., 04
    National Roll-out Proposal  Mid-Sept., 04
    Management Approval   Nov. 1, 04
    Required FTEs
    Required Funding
    Products to be supported by the Broad Market Test Initiatives
    Main Focus (in order of priority)
    Motilium
    Gyno-Daktarin
    Sibelium
    Tag-Ons
    Pevisone
    Daktarin
    Potential Pilot Test Sales & Opex Impact
    How to measure?
    Pre and Post survey to measure the change
    Monthly survey to monitor the change in customers attitude and sales off take
    Monthly report from sales reps. / supervisors / project leader for qualitative feedback
    Senior consumer research manager will be responsible for the tracking study


     

  • 最热医院医药下载

    没有任何图片PPT下载资源
     
    网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!) 【发表评论
    PPT搜索